Feasibility of Providing Cognitive Remediation to People With Schizophrenia in a Clinical Network
- Conditions
- Schizophrenia
- Interventions
- Behavioral: Targeted cognitive trainingBehavioral: Computer controlBehavioral: Bridging groupsBehavioral: Health and wellness groups
- Registration Number
- NCT00930150
- Lead Sponsor
- National Institute of Mental Health (NIMH)
- Brief Summary
This study will test whether a cognitive remediation program to treat people with schizophrenia can be successfully implemented in a network of research clinics.
- Detailed Description
Neurocognitive impairments, or problems with thinking and brain function, are a core component of schizophrenia. Such impairments, which can range from moderate to severe, are strongly associated with decreased benefit from psychiatric rehabilitation and problems with treatment adherence, socialization, employment, quality of life, and relapse. Researchers believe that the failure of medication to improve cognition may occur because medication treatment lacks cognitive stimulation. Cognitive remediation programs are a way to provide that stimulation, and they have shown moderate efficacy in improving cognition in people with schizophrenia. Implementing these cognitive remediation programs as part of schizophrenia treatment has occurred only at individual sites with highly trained research personnel. This study will test whether cognitive remediation programs for schizophrenia can be feasibly implemented at a network of sites that do not specialize in cognitive remediation research. This pilot study will gather preliminary efficacy data, but a larger study is required to draw definitive conclusions about treatment effects.
Participation in this study will last approximately 8 weeks. Participants will be randomly assigned to the Posit Science intervention group or the control group. Those in the Posit Science group will receive targeted cognitive training (TCT)-40 hours of adaptive computer exercises-and participate in a weekly bridging group that helps participants apply cognitive skills to everyday contexts. Length of the TCT may vary, depending on the availability of participants to complete the exercises. Those in the control group will play commercially available video games for the same number of hours and participate in a weekly health and wellness group. All participants will undergo assessments at baseline, mid-treatment, and post-treatment. Assessments will include self-report questionnaires and clinical interviews.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 52
-
Demonstrates adequate decisional capacity to make a choice about participating in the research study
-
Diagnosis of schizophrenia or schizoaffective disorder, as defined by DSM-IV-TR criteria and confirmed by the Structured Clinical Interview for DSM-IV (SCID)
-
Positive and Negative Syndrome Scale (PANSS) hallucinatory behavior, unusual thought content, and conceptual disorganization ratings of no greater than moderately severe (i.e., item scores must be less than or equal to 5)
-
Meets all of the following cognitive performance and English language criteria:
- Learned English before age 12
- Able to complete the baseline Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB) validly, based on the judgment of the investigator
- Raw score of 37 or greater on the Wide Range Achievement Test, reading subtest, 3rd edition (WRAT-3), used to establish minimum sixth grade reading level and estimated premorbid IQ
-
Able to state specific goals relevant to the intervention that participant would like to achieve
-
Able to participate in the computerized intervention, based on the judgment of the investigator
- Psychiatric hospitalization within 8 weeks of random assignment
- Adjustment to antipsychotic treatment within 4 weeks of random assignment
- Currently taking an anticholinergic medication
- DSM-IV diagnosis of alcohol or substance abuse (other than nicotine) within the last month or a DSM-IV diagnosis of alcohol or substance dependence (other than nicotine) within the last 6 months
- History of mental retardation, pervasive developmental disorder, or other neurological disorder (such as a traumatic brain injury, epilepsy, or Parkinson 's disease)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Posit Science Intervention Targeted cognitive training Participants will receive targeted cognitive training and participate in a bridging group. Posit Science Intervention Bridging groups Participants will receive targeted cognitive training and participate in a bridging group. Control Computer control Participants will play commercially available computer games and participate in weekly groups to discuss health and wellness. Control Health and wellness groups Participants will play commercially available computer games and participate in weekly groups to discuss health and wellness.
- Primary Outcome Measures
Name Time Method Feasibility of a multisite trial using cognitive remediation Measured at post-treatment
- Secondary Outcome Measures
Name Time Method Effect of cognitive remediation on functional outcomes, including change from baseline on UCSD Performance Based Skills Assessment (UPSA) total score, Specific Levels of Functioning (SLOF) total score, and Cognitive Assessment Interview (CAI) total score Measured at post-treatment
Trial Locations
- Locations (9)
Philadelphia VA Medical Center-116A
๐บ๐ธPhiladelphia, Pennsylvania, United States
Yale University/Connecticut Mental Health Center
๐บ๐ธNew Haven, Connecticut, United States
University of Massachusetts
๐บ๐ธWorcester, Massachusetts, United States
The University of North Carolina
๐บ๐ธChapel Hill, North Carolina, United States
Emory University
๐บ๐ธAtlanta, Georgia, United States
Medical College of Georgia
๐บ๐ธAugusta, Georgia, United States
University of Iowa Hospital
๐บ๐ธIowa City, Iowa, United States
University of Texas Health Science Center at San Antonio
๐บ๐ธSan Antonio, Texas, United States
University of Minnesota School of Medicine
๐บ๐ธMinneapolis, Minnesota, United States